NCT06876636 2025-07-29
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
Xijing Hospital
Phase NA Active not recruiting
Clinical Trials
12 trialsNCT00458796 2022-05-27
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone
University of Leeds
Phase NA Terminated
NCT01623908 2021-06-22
BLAZE
First Affiliated Hospital, Sun Yat-Sen University
Phase NA Terminated
NCT01409811 2020-05-08
Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid
City of Hope Medical Center
Phase NA Terminated
NCT01772719 2019-11-18
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
University of Louisville
Phase NA Terminated
NCT01205646 2019-04-12
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT02069340 2017-04-11
Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid
University of Southern California
Phase NA Withdrawn
NCT00489905 2013-10-23
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Hospital Authority, Hong Kong
Phase NA Completed
NCT00114270 2013-03-26
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
National Cancer Institute (NCI)
Phase NA Completed
NCT00126386 2011-11-21
Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
AHS Cancer Control Alberta
Phase NA Completed
NCT00087659 2009-11-23
A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
Novartis
Phase NA Completed
NCT00520052 2007-08-23
Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer
Wirral University Teaching Hospital NHS Trust
Phase NA Completed